GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,912,049 | +30.7% | 864,291 | +56.7% | 0.01% | +33.3% |
| Q2 2023 | $32,833,035 | +3.4% | 551,445 | -1.6% | 0.01% | 0.0% |
| Q1 2023 | $31,753,914 | -22.5% | 560,627 | +1.6% | 0.01% | -33.3% |
| Q4 2022 | $40,998,600 | +24.3% | 552,021 | -0.3% | 0.01% | +12.5% |
| Q3 2022 | $32,983,000 | +1.2% | 553,704 | -4.7% | 0.01% | +14.3% |
| Q2 2022 | $32,604,000 | -24.2% | 580,750 | -0.4% | 0.01% | -12.5% |
| Q1 2022 | $43,015,000 | -1.9% | 583,014 | -4.0% | 0.01% | +14.3% |
| Q4 2021 | $43,826,000 | -7.1% | 606,996 | -1.4% | 0.01% | -12.5% |
| Q3 2021 | $47,191,000 | -2.9% | 615,910 | -1.8% | 0.01% | -11.1% |
| Q2 2021 | $48,615,000 | +22.6% | 627,054 | -2.5% | 0.01% | +28.6% |
| Q1 2021 | $39,665,000 | +2.9% | 643,183 | +8.8% | 0.01% | -12.5% |
| Q4 2020 | $38,547,000 | +32.0% | 591,039 | +0.2% | 0.01% | +33.3% |
| Q3 2020 | $29,196,000 | -0.4% | 589,606 | -4.1% | 0.01% | -14.3% |
| Q2 2020 | $29,326,000 | -44.8% | 614,679 | -50.8% | 0.01% | -53.3% |
| Q1 2020 | $53,088,000 | -26.7% | 1,248,261 | +1.5% | 0.02% | -6.2% |
| Q4 2019 | $72,437,000 | +13.2% | 1,230,249 | -1.7% | 0.02% | +6.7% |
| Q3 2019 | $63,964,000 | +23.8% | 1,251,251 | +2.5% | 0.02% | +25.0% |
| Q2 2019 | $51,655,000 | -14.0% | 1,221,143 | +0.5% | 0.01% | -20.0% |
| Q1 2019 | $60,032,000 | +16.6% | 1,214,963 | +2.2% | 0.02% | +7.1% |
| Q4 2018 | $51,476,000 | -24.0% | 1,189,386 | -0.3% | 0.01% | -17.6% |
| Q3 2018 | $67,708,000 | +12.7% | 1,192,871 | +0.2% | 0.02% | +13.3% |
| Q2 2018 | $60,067,000 | +4.2% | 1,190,383 | +2.9% | 0.02% | 0.0% |
| Q1 2018 | $57,647,000 | +20.2% | 1,157,119 | -0.9% | 0.02% | +25.0% |
| Q4 2017 | $47,967,000 | +32.6% | 1,167,072 | -4.1% | 0.01% | +33.3% |
| Q3 2017 | $36,181,000 | -12.1% | 1,217,390 | -1.9% | 0.01% | -25.0% |
| Q2 2017 | $41,155,000 | +15.2% | 1,241,485 | +2.9% | 0.01% | +20.0% |
| Q1 2017 | $35,720,000 | +21.4% | 1,205,926 | +1.7% | 0.01% | +11.1% |
| Q4 2016 | $29,415,000 | +16.8% | 1,185,618 | +6.2% | 0.01% | +12.5% |
| Q3 2016 | $25,191,000 | -9.3% | 1,116,136 | -4.2% | 0.01% | -11.1% |
| Q2 2016 | $27,763,000 | +5.1% | 1,165,039 | +1.3% | 0.01% | 0.0% |
| Q1 2016 | $26,407,000 | -17.0% | 1,149,727 | +0.5% | 0.01% | -18.2% |
| Q4 2015 | $31,812,000 | +35.0% | 1,143,537 | +0.2% | 0.01% | +37.5% |
| Q3 2015 | $23,567,000 | +14.8% | 1,140,699 | +42.6% | 0.01% | +33.3% |
| Q2 2015 | $20,530,000 | -22.3% | 799,771 | -23.6% | 0.01% | -25.0% |
| Q1 2015 | $26,434,000 | +15.4% | 1,047,308 | +8.7% | 0.01% | +14.3% |
| Q4 2014 | $22,899,000 | +17.4% | 963,384 | -2.9% | 0.01% | +16.7% |
| Q3 2014 | $19,512,000 | +17.7% | 991,932 | +43.2% | 0.01% | +20.0% |
| Q2 2014 | $16,573,000 | -31.2% | 692,850 | -23.5% | 0.01% | -37.5% |
| Q1 2014 | $24,095,000 | +53.2% | 906,143 | +16.3% | 0.01% | +60.0% |
| Q4 2013 | $15,728,000 | +20.5% | 779,350 | +4.3% | 0.01% | 0.0% |
| Q3 2013 | $13,051,000 | +161.0% | 747,501 | +152.1% | 0.01% | +150.0% |
| Q2 2013 | $5,000,000 | – | 296,548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |